Literature DB >> 29366871

Cytochrome P450 1A1 (CYP1A1) protects against nonalcoholic fatty liver disease caused by Western diet containing benzo[a]pyrene in mice.

Shigeyuki Uno1, Daniel W Nebert2, Makoto Makishima3.   

Abstract

The Western diet contributes to nonalcoholic fatty liver disease (NAFLD) pathogenesis. Benzo[a]pyrene (BaP), a prototypical environmental pollutant produced by combustion processes, is present in charcoal-grilled meat. Cytochrome P450 1A1 (CYP1A1) metabolizes BaP, resulting in either detoxication or metabolic activation in a context-dependent manner. To elucidate a role of CYP1A1-BaP in NAFLD pathogenesis, we compared the effects of a Western diet, with or without oral BaP treatment, on the development of NAFLD in Cyp1a1(-/-) mice versus wild-type mice. A Western diet plus BaP induced lipid-droplet accumulation in liver of Cyp1a1(-/-) mice, but not wild-type mice. The hepatic steatosis observed in Cyp1a1(-/-) mice was associated with increased cholesterol, triglyceride and bile acid levels. Cyp1a1(-/-) mice fed Western diet plus BaP had changes in expression of genes involved in bile acid and lipid metabolism, and showed no increase in Cyp1a2 expression but did exhibit enhanced Cyp1b1 mRNA expression, as well as hepatic inflammation. Enhanced BaP metabolic activation, oxidative stress and inflammation may exacerbate metabolic dysfunction in liver of Cyp1a1(-/-) mice. Thus, Western diet plus BaP induces NAFLD and hepatic inflammation in Cyp1a1(-/-) mice in comparison to wild-type mice, indicating a protective role of CYP1A1 against NAFLD pathogenesis.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Benzo[a]pyrene; Bile acids; Inflammation; Lipogenesis; Nonalcoholic fatty liver disease; Western diet

Mesh:

Substances:

Year:  2018        PMID: 29366871      PMCID: PMC5831517          DOI: 10.1016/j.fct.2018.01.029

Source DB:  PubMed          Journal:  Food Chem Toxicol        ISSN: 0278-6915            Impact factor:   6.023


  49 in total

1.  Dietary exposure estimation of benzo[a]pyrene and cancer risk assessment.

Authors:  Byung Mu Lee; Geun Ae Shim
Journal:  J Toxicol Environ Health A       Date:  2007-08

2.  Targeted knockout of Cyp1a1 gene does not alter hepatic constitutive expression of other genes in the mouse [Ah] battery.

Authors:  T P Dalton; M Z Dieter; R S Matlib; N L Childs; H G Shertzer; M B Genter; D W Nebert
Journal:  Biochem Biophys Res Commun       Date:  2000-01-07       Impact factor: 3.575

3.  Rabbit serum hypertriglyceridemia after administration of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD).

Authors:  D W Brewster; D W Bombick; F Matsumura
Journal:  J Toxicol Environ Health       Date:  1988

4.  Arsenic co-exposure potentiates benzo[a]pyrene genotoxicity.

Authors:  Andrew Maier; Brenda L Schumann; Xiaoqing Chang; Glenn Talaska; Alvaro Puga
Journal:  Mutat Res       Date:  2002-05-27       Impact factor: 2.433

5.  Identification of a nuclear receptor for bile acids.

Authors:  M Makishima; A Y Okamoto; J J Repa; H Tu; R M Learned; A Luk; M V Hull; K D Lustig; D J Mangelsdorf; B Shan
Journal:  Science       Date:  1999-05-21       Impact factor: 47.728

6.  Regulation of lipoprotein lipase by the oxysterol receptors, LXRalpha and LXRbeta.

Authors:  Y Zhang; J J Repa; K Gauthier; D J Mangelsdorf
Journal:  J Biol Chem       Date:  2001-09-18       Impact factor: 5.157

7.  Bile acid reduces the secretion of very low density lipoprotein by repressing microsomal triglyceride transfer protein gene expression mediated by hepatocyte nuclear factor-4.

Authors:  Hisako Hirokane; Mayuko Nakahara; Shizuko Tachibana; Makoto Shimizu; Ryuichiro Sato
Journal:  J Biol Chem       Date:  2004-08-26       Impact factor: 5.157

8.  Vitamin D3 modulates the expression of bile acid regulatory genes and represses inflammation in bile duct-ligated mice.

Authors:  Michitaka Ogura; Shigeru Nishida; Michiyasu Ishizawa; Kenichi Sakurai; Makoto Shimizu; Sadanori Matsuo; Sadao Amano; Shigeyuki Uno; Makoto Makishima
Journal:  J Pharmacol Exp Ther       Date:  2008-11-06       Impact factor: 4.030

9.  Modulation of bile acid metabolism by 1alpha-hydroxyvitamin D3 administration in mice.

Authors:  Shigeru Nishida; Jun Ozeki; Makoto Makishima
Journal:  Drug Metab Dispos       Date:  2009-07-06       Impact factor: 3.922

10.  The LXR ligand T0901317 induces severe lipogenesis in the db/db diabetic mouse.

Authors:  Jeffrey W Chisholm; Jenny Hong; Scott A Mills; Richard M Lawn
Journal:  J Lipid Res       Date:  2003-08-16       Impact factor: 5.922

View more
  6 in total

1.  Different morphological and gene expression profile in placentas of the same sickle cell anemia patient in pregnancies of opposite outcomes.

Authors:  Letícia C Baptista; Camilla O Figueira; Bruno B Souza; Kleber Y Fertrin; Arthur Antolini; Fernando F Costa; Mônica B de Melo; Maria Laura Costa
Journal:  Exp Biol Med (Maywood)       Date:  2019-02-28

Review 2.  Environmental Toxicants and NAFLD: A Neglected yet Significant Relationship.

Authors:  Sangam Rajak; Sana Raza; Archana Tewari; Rohit A Sinha
Journal:  Dig Dis Sci       Date:  2021-08-12       Impact factor: 3.487

3.  Modulation of Tetrachloroethylene-Associated Kidney Effects by Nonalcoholic Fatty Liver or Steatohepatitis in Male C57BL/6J Mice.

Authors:  Joseph A Cichocki; Yu-Syuan Luo; Shinji Furuya; Abhishek Venkatratnam; Kranti Konganti; Weihsueh A Chiu; David W Threadgill; Igor P Pogribny; Ivan Rusyn
Journal:  Toxicol Sci       Date:  2019-01-01       Impact factor: 4.849

Review 4.  Cytochrome P450 1B1: role in health and disease and effect of nutrition on its expression.

Authors:  Bakht Ramin Shah; Wei Xu; Jan Mraz
Journal:  RSC Adv       Date:  2019-07-04       Impact factor: 4.036

5.  Membrane Remodeling as a Key Player of the Hepatotoxicity Induced by Co-Exposure to Benzo[a]pyrene and Ethanol of Obese Zebrafish Larvae.

Authors:  Muhammad Imran; Odile Sergent; Arnaud Tête; Isabelle Gallais; Martine Chevanne; Dominique Lagadic-Gossmann; Normand Podechard
Journal:  Biomolecules       Date:  2018-05-14

6.  CYP450 drug inducibility in NAFLD via an in vitro hepatic model: Understanding drug-drug interactions in the fatty liver.

Authors:  Camilo Rey-Bedon; Peony Banik; Aslihan Gokaltun; O Hofheinz; Martin L Yarmush; M Korkut Uygun; O Berk Usta
Journal:  Biomed Pharmacother       Date:  2022-01-02       Impact factor: 6.529

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.